Harte Hanks’ ADT VR campaign wins four ECHO awards
PHILADELPHIA, March 19, 2020 (GLOBE NEWSWIRE) — Harte Hanks (NYSE: HHS), a leader in developing customer experiences and behavioral marketing, […]
Greenlane to Report Fourth Quarter and Full Year 2019 Results on March 30, 2020
BOCA RATON, Fla., March 19, 2020 (GLOBE NEWSWIRE) — Greenlane Holdings, Inc. (Nasdaq: GNLN) (“Greenlane”), one of the largest global […]
Energy Focus, Inc. Reports Fourth Quarter and Fiscal Year 2019 Financial Results
Fourth Quarter Net Sales Increase 21% Sequentially and 13% Year-over-Year to $3.5 MillionConference Call to be Held Today at 11AM […]
DAVE & BUSTER’S ENTERTAINMENT, INC. ADOPTS LIMITED DURATION SHAREHOLDER RIGHTS PLAN
DALLAS, March 19, 2020 (GLOBE NEWSWIRE) — Dave & Buster’s Entertainment, Inc., (NASDAQ:PLAY), (“Dave & Buster’s” or “the Company”), an […]
Datasea Completes Installation of Epidemic Prevention and Control Systems in Two K-12 Schools as Part of Ongoing Pilot Program
Non-contact temperature measuring terminals to be installed in four additional pilot locationsNEW YORK, March 19, 2020 (GLOBE NEWSWIRE) — Datasea Inc. […]
Duluth Holdings Inc. Announces Fourth Quarter and Fiscal 2019 Financial Results
MOUNT HOREB, Wis., March 19, 2020 (GLOBE NEWSWIRE) — Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading” or the […]
Chanticleer Holdings Announces Results of Shareholder Vote
CHARLOTTE, N.C., March 19, 2020 (GLOBE NEWSWIRE) — Chanticleer Holdings, Inc. (NASDAQ:BURG) (“Chanticleer” or the “Company”), owner, operator, and franchisor […]
BOQI International Medical Completes Acquisition of Chongqing Guanzan Technology
New York, March 19, 2020 (GLOBE NEWSWIRE) — BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced […]
Algernon to Support Planned Phase 2 Trial of Ifenprodil for Coronavirus
VANCOUVER, British Columbia, March 19, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or […]
Phathom Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Clinical Trial Status and Business Updates
Successfully Finished 2019 with Initiation of Two Pivotal Phase 3 Trials for Vonoprazan in Erosive Esophagitis (PHALCON-EE) and H. pylori […]
